Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Early Phase 1 Interventional

Regional Nerve Blocks to Improve Analgesia and Recovery in Older Adults Undergoing Spinal Fusion

ClinicalTrials.gov ID: NCT05461092

Public ClinicalTrials.gov record NCT05461092. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 8:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05461092
Recruitment status
Recruiting
Study type
Interventional
Phase
Early Phase 1
Lead sponsor
University of Iowa
Other
Enrollment
50 participants

Conditions and interventions

Interventions

  • 3D CAM Delirium Severity Scoring Other
  • Blood Test Diagnostic Test
  • Daily Pain Trajectory Other
  • Delirium Rating Scale-Revised-98 (DRS) Other
  • Fear Avoidance Beliefs Questionnaire (FABQ) Other
  • Generalized Anxiety Disorder 7-item (GAD-7) scale Other
  • Numerical Rating Score (NRS) Other
  • Opioid Equivalents measured by Morphine Milligram Equivalents (MME) Other
  • Opioid Side Effects and Likeability Questionnaire Other
  • Oswestry Disability Index (ODI) Other
  • PROMIS-Pain Interference Other
  • Pain Catastrophizing Other
  • Patient Health Questionnaire depression scale (PHQ-8) Other
  • Quality of Recovery 15 Other
  • Saint Louis University Mental Status Examination (SLUMs) Other
  • Tampa Scale of Kinesiophobia Other
  • Telephone Interview for Cognitive Status - Modified (TICS-M) Other
  • Thoracolumbar Interfascial Plane (TLIP) Block of bupivacaine Drug

Other · Diagnostic Test · Drug

Eligibility (public fields only)

Age range
65 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2023
Primary completion
Dec 30, 2026
Completion
Dec 30, 2026
Last update posted
Mar 26, 2026

2024 – 2026

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
University of Iowa Iowa City Iowa 52242 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05461092, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05461092 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →